A comparative trial on eradicative and clinical effects of Kampo formulas for multiply-resistant organisms in elderly bacterial carriers.

A comparative trial on eradicative and clinical effects of Kampo formulas for multiply-resistant organisms in elderly bacterial carriers. - Effect of Kampo formulas on multiply-resistant organisms.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004549

Enrollment

Registered

2010-11-15

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly bacterial carriers with multiply-resistant organisms.

Interventions

Oral administration of hochuekkito Oral administration of juzentaihoto Non-administration of Kampo formulas

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Elderly bacterial carriers with multiply-resistant organisms.

Exclusion criteria

Exclusion criteria: 1.Patients with severe diseases whose serum albumin level is under 2.7 g/dl or concentration of hemoglobin is under 9.0 g/dl. 2. Patients with infections who continue the fever above 38 degrees C.

Design outcomes

Primary

Measure	Time frame
Eradicative rates of multiply-resistant organisms.	—

Secondary

Measure	Time frame
NK-cell activity	—

Countries

Japan

Contacts

Public ContactHirozo Goto

University of Toyama Department of Japanese Oriental Medicine, Graduate school of Medicine and Pharmaceutical Sciences

076-434-7393

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026